Immunotherapy — targeted drug combination improves survival in advanced kidney cancer

Lenvatinib plus pembrolizumab yields better overall survival than single-agent sunitinib when given as first-line therapy in untreated patients with metastatic kidney cancer The combination also improved progression-free survival and overall response rate BOSTON – Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients…

Details

Biden Administration Moves to End Work Requirements in Medicaid

The Biden administration is beginning to roll back a signature Trump administration health policy goal of requiring people to work to receive Medicaid coverage. In separate actions Friday, officials notified states with approved work requirements that the administration planned to withdraw the approvals, and it rescinded a Trump-era online guidance document inviting states to pursue…

Details

The Love Language of Butter

LONDON — Around Valentine’s Day, I raise my glass particularly high to any couple who managed to save up any top chat for a romantic dinner for two. What on earth is there to talk about when you haven’t been anywhere or done anything for a very long time? In the absence of such discussion,…

Details